Clinical trial
S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by…
NCT00003416 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00003416 |
|---|---|
| Title | S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia |
| Official title | S9805, Phase II Study of Tandem High Dose Melphalan Supported by Peripheral Blood Stem Cell Support in Waldenstrom's Macroglobulinemia (WM) |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, recombinant interferon alfa, dexamethasone, melphalan, peripheral blood stem cell transplantation |
| Enrollment | 9 |
| Start date | Sep 1, 1998 |
| Primary completion | Aug 1, 2000 |
| Completion | Jan 1, 2004 |
| First posted | Aug 3, 2004 |
| Last update posted | Mar 6, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: